Enhanced tumor growth caused by anti-Th-B antiserum due to a possible activation of suppressor T-cells.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D001666:Binding Sites, Antibody; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D007116:Immunization, Passive; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D008264:Macrophages / Q000276:immunology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009101:Multiple Myeloma / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology; D012510:Sarcoma 180 / Q000276:immunology* / Q000473:pathology; D013154:Spleen / Q000276:immunology / Q000637:transplantation; D013601:T-Lymphocytes / Q000276:immunology*; D013950:Thymus Gland / Q000276:immunology / Q000637:transplantation; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm